Company Update

CalciMedica, Inc. announced the discontinuation of its Phase 2 KOURAGE clinical trial based on a recommendation from the trial’s Independent Data Monitoring Committee, which also impacts the company's financial guidance. The company now expects its existing cash, cash equivalents, and short-term investments to fund operations into the fourth quarter of 2026.